South Eastern Sydney Primary Health Network has one of the highest prevalence of CHB in Australia (1.45%).
Treatment for hepatitis B can reduce a patient’s risk of liver cancer by 50% in a few years. Identifying and monitoring people with chronic hepatitis B infection allows for timely identification of cancer and liver disease, or even prevention, through the institution of effective treatment. Vaccination and treatment for hepatitis B is available and effective.
The evening will be presented by Prof Andrew Lloyd
• Know who to test and how to interpret test results.
• Improve the outcome of patients through early diagnosis, follow up and appropriate management (including vaccination of contacts)
• Describe the intervention points throughout the natural history of HBV
• Identify the different treatment options available, and the need for lifelong monitoring, for people living with chronic HBV.
This is a FREE course for GPs, nurses and allied health workers.
This course has been funded by New South Wales Health.
Conditions of registration:
Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before Friday 19 May 2017 will not incur a cancellation fee. Cancellations received in writing after Friday 19 May 2017 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM.
As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to firstname.lastname@example.org.